Climb Bio Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Climb Bio is a biotechnology research company focused on immune-mediated diseases, where the immune system targets the body's tissues and can cause organ damage or death. The company aims to modulate the pathways that drive these diseases to extend the period patients live without active disease when current therapies fall short. Its work addresses conditions affecting a substantial share of the population, highlighting an unmet medical need in immune-related disorders. Based in Wellesley, Massachusetts, the organization functions as a small to mid-sized enterprise within the biotech sector. In 2025 it entered into an exclusive license for MIL116 (now CLYM116) for development outside Greater China, and the company has engaged with the scientific community at industry events such as Kidney Week 2025.